NCT01364857 2025-12-22
CONAPE
University Hospital, Tours
Phase NA Completed
Clinical Trials
8 trialsNCT04947124 2025-01-20
A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101
Qlaris Bio, Inc.
Phase 2 Completed
NCT05495269 2025-01-20
Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
Qlaris Bio, Inc.
Phase 2 Completed
NCT04447846 2023-05-25
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2 Completed
NCT02332655 2022-03-02
Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 1/2 Completed
NCT04999618 2021-11-04
DOUBLE-SKIN
Center for Vascular Pathology, Moscow
Phase 4 Completed
NCT03047980 2021-11-01
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2/3 Completed
NCT00639730 2010-05-27
Use of the Atkins Diet for Children With Sturge Weber Syndrome
Johns Hopkins University
Phase 1 Completed